SCHEMBL25854290

SCHEMBL25854290

CC(=O)CCC(C)SSc1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EHMT2 Q96KQ7 1/20 0.44
EHMT1 Q9H9B1 1/20 0.44
APOBEC3G Q9HC16 1/20 0.44
SMN1; SMN2 Q16637 7/20 0.44
HPGD P15428 4/20 0.44
HSD17B10 Q99714 2/20 0.44
ALDH1A1 P00352 10/20 0.43
MAPT P10636 2/20 0.42
KMT2A Q03164 4/20 0.40
RAB9A P51151 3/20 0.40
MEN1 O00255 2/20 0.40
NPC1 O15118 2/20 0.40
PKM P14618 1/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 2/20 0.39
CYP1A2 P05177 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALOX15 P16050 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16132816 0.89 ALDH1A1 (0.54) EHMT2EHMT1APOBEC3GSMN1; SMN2HPGD
SCHEMBL1395632 0.89 ALDH1A1 (0.54) EHMT2EHMT1APOBEC3GSMN1; SMN2HPGD
SCHEMBL24393470 0.85 HDAC6 (0.46) EHMT2EHMT1APOBEC3GSMN1; SMN2HPGD
SCHEMBL25853943 0.85 SMN1; SMN2 (0.44) EHMT2EHMT1APOBEC3GSMN1; SMN2HPGD
SCHEMBL836437 0.85 SMN1; SMN2 (0.44) EHMT2EHMT1APOBEC3GSMN1; SMN2HPGD
SCHEMBL2157165 0.84 SMN1; SMN2 (0.44) EHMT2EHMT1APOBEC3GSMN1; SMN2HPGD
SCHEMBL19193751 0.83 EHMT2 (0.44) EHMT2EHMT1APOBEC3GSMN1; SMN2HPGD
SCHEMBL18958956 0.82 LMNA (0.40) EHMT2EHMT1APOBEC3GSMN1; SMN2HPGD
SCHEMBL2610936 0.80 EHMT2 (0.52) EHMT2EHMT1APOBEC3GSMN1; SMN2HPGD
SCHEMBL31005434 0.80 LMNA (0.39) EHMT2EHMT1APOBEC3GSMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11696956-B2 Bicyclic peptide ligands specific for EphA2 BICYCLETX LIMITED (GB) 2023-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11696956-B2 Bicyclic peptide ligands specific for EphA2 EPHA2, EPHB2, ERBB2 EHMT2 1108/4885EHMT1 2040/4885APOBEC3G 2333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.